Merck Quarterly Profit Tops Expectations on COVID Pill Surprise

Merck on Thursday reported higher-than-expected third-quarter results on surprisingly strong demand for its COVID-19 treatment, primarily in Japan, and raised its sales forecast for the drug.
Reuters Health Information

source https://www.medscape.com/s/viewarticle/997750?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?